CellWell record HH-102652
RETICULOCYTE HEMOGLOBIN COUNT AS A DIAGNOSTIC MARKER OF FUNCTIONAL IRON DEFICIENCY IN BREAST CANCER PATIENTS IN LAHORE
S. Khan; Saima Irum; Sarosh Ahmed; Khan Niazi
Journal of Medical & Health Sciences Review ยท 2026
In plain language
A review examined reticulocyte hemoglobin content as a tool to detect functional iron deficiency in breast cancer patients, since standard markers like ferritin and transferrin saturation become unreliable during cancer-related inflammation.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-102652
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.